Reversal of Mitochondrial Transhydrogenase Causes Oxidative Stress in Heart Failure.
The study suggests that targeting Nnt-mediated oxidative stress with SS-31 could potentially impact mortality in heart failure, but further research in humans is necessary.
Where it sits
this study against the rest of the ss-31 corpusSummary and findings
This study examined the role of mitochondrial reactive oxygen species (ROS) in heart failure, particularly focusing on the nicotinamide nucleotide transhydrogenase (Nnt) enzyme. The tetrapeptide SS-31 was investigated for its potential to rescue mortality in a mouse model of pressure overload-induced heart failure. The findings suggest a link between Nnt function and oxidative stress in heart failure.
Abstract
Mitochondrial reactive oxygen species (ROS) play a central role in most aging-related diseases. ROS are produced at the respiratory chain that demands NADH for electron transport and are eliminated by enzymes that require NADPH. The nicotinamide nucleotide transhydrogenase (Nnt) is considered a key antioxidative enzyme based on its ability to regenerate NADPH from NADH. Here, we show that pathological metabolic demand reverses the direction of the Nnt, consuming NADPH to support NADH and ATP production, but at the cost of NADPH-linked antioxidative capacity. In heart, reverse-mode Nnt is the dominant source for ROS during pressure overload. Due to a mutation of the Nnt gene, the inbred mouse strain C57BL/6J is protected from oxidative stress, heart failure, and death, making its use in cardiovascular research problematic. Targeting Nnt-mediated ROS with the tetrapeptide SS-31 rescued mortality in pressure overload-induced heart failure and could therefore have therapeutic potential in patients with this syndrome.
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.